6-33174143-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080680.3(COL11A2):​c.2484+22C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.744 in 1,597,208 control chromosomes in the GnomAD database, including 445,508 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 47111 hom., cov: 29)
Exomes 𝑓: 0.74 ( 398397 hom. )

Consequence

COL11A2
NM_080680.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0620

Publications

12 publications found
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 13
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive nonsyndromic hearing loss 53
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • otospondylomegaepiphyseal dysplasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-33174143-G-C is Benign according to our data. Variant chr6-33174143-G-C is described in ClinVar as Benign. ClinVar VariationId is 262309.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.949 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.2484+22C>G intron_variant Intron 32 of 65 ENST00000341947.7 NP_542411.2 P13942A0A0C4DFS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.2484+22C>G intron_variant Intron 32 of 65 5 NM_080680.3 ENSP00000339915.2 A0A0C4DFS1
COL11A2ENST00000374708.8 linkc.2226+22C>G intron_variant Intron 30 of 63 5 ENSP00000363840.4 Q4VXY6
COL11A2ENST00000361917.6 linkc.1056+22C>G intron_variant Intron 19 of 23 5 ENSP00000355123.2 H0YIS1
COL11A2ENST00000477772.1 linkn.272+2866C>G intron_variant Intron 5 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.784
AC:
118804
AN:
151600
Hom.:
47067
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.873
Gnomad AMI
AF:
0.622
Gnomad AMR
AF:
0.789
Gnomad ASJ
AF:
0.801
Gnomad EAS
AF:
0.972
Gnomad SAS
AF:
0.905
Gnomad FIN
AF:
0.708
Gnomad MID
AF:
0.816
Gnomad NFE
AF:
0.718
Gnomad OTH
AF:
0.799
GnomAD2 exomes
AF:
0.778
AC:
171874
AN:
220918
AF XY:
0.780
show subpopulations
Gnomad AFR exome
AF:
0.875
Gnomad AMR exome
AF:
0.797
Gnomad ASJ exome
AF:
0.810
Gnomad EAS exome
AF:
0.974
Gnomad FIN exome
AF:
0.693
Gnomad NFE exome
AF:
0.708
Gnomad OTH exome
AF:
0.776
GnomAD4 exome
AF:
0.739
AC:
1068806
AN:
1445490
Hom.:
398397
Cov.:
50
AF XY:
0.744
AC XY:
533925
AN XY:
717806
show subpopulations
African (AFR)
AF:
0.883
AC:
29098
AN:
32936
American (AMR)
AF:
0.800
AC:
34669
AN:
43362
Ashkenazi Jewish (ASJ)
AF:
0.810
AC:
20890
AN:
25778
East Asian (EAS)
AF:
0.982
AC:
37946
AN:
38626
South Asian (SAS)
AF:
0.888
AC:
74689
AN:
84066
European-Finnish (FIN)
AF:
0.700
AC:
35926
AN:
51324
Middle Eastern (MID)
AF:
0.831
AC:
4770
AN:
5742
European-Non Finnish (NFE)
AF:
0.711
AC:
785334
AN:
1103898
Other (OTH)
AF:
0.761
AC:
45484
AN:
59758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
15013
30026
45038
60051
75064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19840
39680
59520
79360
99200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.784
AC:
118903
AN:
151718
Hom.:
47111
Cov.:
29
AF XY:
0.785
AC XY:
58152
AN XY:
74088
show subpopulations
African (AFR)
AF:
0.873
AC:
36097
AN:
41364
American (AMR)
AF:
0.788
AC:
12040
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.801
AC:
2781
AN:
3472
East Asian (EAS)
AF:
0.972
AC:
4971
AN:
5114
South Asian (SAS)
AF:
0.905
AC:
4360
AN:
4820
European-Finnish (FIN)
AF:
0.708
AC:
7439
AN:
10506
Middle Eastern (MID)
AF:
0.823
AC:
242
AN:
294
European-Non Finnish (NFE)
AF:
0.718
AC:
48719
AN:
67856
Other (OTH)
AF:
0.801
AC:
1689
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1215
2430
3645
4860
6075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
864
1728
2592
3456
4320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.717
Hom.:
4771
Bravo
AF:
0.794
Asia WGS
AF:
0.900
AC:
3131
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Otospondylomegaepiphyseal dysplasia, autosomal dominant Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 53 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal recessive Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal dominant nonsyndromic hearing loss 13 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibrochondrogenesis 2 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.6
DANN
Benign
0.27
PhyloP100
-0.062
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2744512; hg19: chr6-33141920; API